OAC
AVDL

OMERS Administration Corp’s Avadel Pharmaceuticals AVDL Stock Holding History

OMERS Administration Corp’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-39,000
Closed -$596K – 1072
2025
Q3 		$596K Hold
39,000
– – ﹤0.01% 688
2025
Q2 		$345K Hold
39,000
– – ﹤0.01% 714
2025
Q1 		$305K Buy
+39,000
New +$327K ﹤0.01% 854
2024
Q3 		– Sell
-13,400
Closed -$188K – 911
2024
Q2 		$188K Buy
+13,400
New +$218K ﹤0.01% 896

Other funds holding AVDL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GJL
Gendell Jeffrey L $11.3B AUM 163.06% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

OMERS Administration Corp's AVDL Position: Q4 2025 in Review

OMERS Administration Corp sold out of Avadel Pharmaceuticals (AVDL) in Q4 2025, closing a stake of 39,000 shares — an estimated $596K sold.

OMERS Administration Corp first reported a position in AVDL in Q2 2024 and held it in 4 quarters. The position peaked at $596K in Q3 2025. 207 funds tracked by Wall St. Rank hold AVDL as of Q4 2025.

  • OMERS Administration Corp reported no remaining Avadel Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • OMERS Administration Corp sold 39,000 Avadel Pharmaceuticals shares in Q4 2025, an estimated $596K.
  • OMERS Administration Corp first reported a position in Avadel Pharmaceuticals in Q2 2024 and held it in 4 quarters.
  • OMERS Administration Corp's Avadel Pharmaceuticals position peaked at $596K in Q3 2025.
  • 207 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q4 2025.

Based on OMERS Administration Corp's 13F filing for Q4 2025, filed 13 Feb 2026.